A. Mayor Ibarguren

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series

A. Mayor Ibarguren, Espinosa Arranz Enrique, P. Diana, 2021, JAAD case reports.

Are Oral Mucosal Changes a Sign of COVID-19? A Cross-Sectional Study at a Field Hospital

P. Herranz Pinto, M. Feito Rodríguez, A. Mayor Ibarguren, 2021, Actas Dermo-Sifiliográficas (English Edition).

Are Oral Mucosal Changes a Sign of COVID-19? A Cross-Sectional Study at a Field Hospital.

P. Herranz Pinto, M. Feito Rodríguez, A. Mayor Ibarguren, 2021, Actas dermo-sifiliograficas.

Prevalence of mucocutaneous manifestations in 666 patients with COVID‐19 in a field hospital in Spain: oral and palmoplantar findings

A. Nuno-Gonzalez, P. Herranz Pinto, P. Martín-Carrillo, 2020, The British Journal of Dermatology.

Prevalence of mucocutaneous manifestations, oral and palmoplantar findings in 666 patients with COVID-19 in a field hospital in Spain.

J. A. Almazan, G. G. Casasola, A. Nuno-Gonzalez, 2020, The British journal of dermatology.

Ibrutinib‐induced leg ulcer successfully treated with platelet‐rich plasma

P. Herranz Pinto, L. Quintana Castanedo, A. Mayor Ibarguren, 2021 .

Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer

E. Espinosa Arranz, A. Herrero Ambrosio, P. Zamora Auñón, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.